PIK3CA and glioblastoma: Recent advances, such as NGS, have enabled a more comprehensive coverage, revealing a PIK3CA mutation frequency of 10–11% in larger cohorts (n = 130 [27], and 291 [18], respectively), though rates as high as 30% have been reported in certain multifocal GBM cases [27].